Level Four Advisory Services LLC Purchases 49,307 Shares of CVS Health Corporation $CVS

Key Points

• Level Four Advisory Services LLC increased its stake in CVS Health Corporation by 50.7% during the first quarter, acquiring an additional 49,307 shares, boosting its total holdings to 146,601 shares valued at approximately $9.93 million.
• CVS Health shares recently reported a price increase of 1.1%, with a market cap of $89.98 billion and a P/E ratio of 19.82.
• The company declared a quarterly dividend of $0.665, with an annual yield of 3.7% and a payout ratio of 74.30%.

Level Four Advisory Services LLC boosted its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 50.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 146,601 shares of the pharmacy operator's stock after buying an additional 49,307 shares during the quarter. Level Four Advisory Services LLC's holdings in CVS Health were worth $9,932,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CVS. Tower Research Capital LLC TRC increased its position in CVS Health by 40.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 70,218 shares of the pharmacy operator's stock worth $3,152,000 after buying an additional 20,107 shares during the last quarter. State of Tennessee Department of Treasury grew its position in shares of CVS Health by 4.7% in the fourth quarter. State of Tennessee Department of Treasury now owns 477,251 shares of the pharmacy operator's stock valued at $21,424,000 after purchasing an additional 21,251 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of CVS Health by 14.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,366,403 shares of the pharmacy operator's stock valued at $600,019,000 after purchasing an additional 1,660,321 shares during the last quarter. MGO One Seven LLC grew its position in shares of CVS Health by 4.2% in the fourth quarter. MGO One Seven LLC now owns 21,484 shares of the pharmacy operator's stock valued at $964,000 after purchasing an additional 868 shares during the last quarter. Finally, Coppell Advisory Solutions LLC grew its position in shares of CVS Health by 17.3% in the fourth quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after purchasing an additional 189 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

CVS has been the topic of several research reports. Barclays upped their target price on CVS Health from $79.00 to $80.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research report on Monday, August 4th. Royal Bank Of Canada upped their target price on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Truist Financial increased their price target on CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, CVS Health has a consensus rating of "Buy" and an average price target of $76.67.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the acquisition, the director owned 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.22% of the company's stock.

CVS Health Price Performance

NYSE:CVS traded down $0.2560 during trading hours on Friday, reaching $71.1740. 6,982,068 shares of the company were exchanged, compared to its average volume of 8,748,738. The company has a market capitalization of $90.27 billion, a P/E ratio of 19.88, a P/E/G ratio of 0.79 and a beta of 0.58. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The business has a 50 day moving average of $65.50 and a 200 day moving average of $65.18.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. The firm had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company's revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend was Tuesday, July 22nd. CVS Health's dividend payout ratio (DPR) is currently 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.